The Phage Therapy for Antibiotic Resistance market was valued at USD 313.63 Million in 2024 and is expected to reach USD 1,116.44 Million by 2032, growing at a CAGR of 17.2% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.